Boyd Street Ventures

Since 2006 we’ve backed Yale faculty doing cutting edge research on some of the world’s largest problems. With Yale as our largest investor, we’ve supported teams developing much-needed therapeutics, advanced tools and materials for industry, and critical interventions for a warming planet. Our thesis is that great people and great science lead to great impact. YALE AND NEW HAVEN We are primarily interested in companies with a Yale connection, typically technology developed at and licensed from Yale. We also invest in companies located in the greater New Haven area, and, in exceptional cases, non-Yale/non-New Haven companies in which we have strong, personal connections to the founders or investors or where we can add substantial value. INVESTING IN PEOPLE In making investment decisions, we weigh the strength of the team as much as the technology or markets being addressed – often more. We look for creative thinking, high intelligence, passion, and a deep commitment to working hard for success. Building great businesses takes time and hard work. THERE AT THE START We are interested in investing as early as a good idea comes together, or later, as the team is formed and the business develops. We have been co-founders of a number of our portfolio companies, and find that the most rewarding (and hardest) thing we do. We typically make first investments of $500,000 to $1 million, and, if a company is tracking well, look to invest an additional $2 to $2.5 million over multiple financing rounds. We are happy to syndicate with other investors who share our views and approach to investing.

We have two funds: Future Ventures: The way consumers want to engage with their money and plan for their financial future is changing. Through Northwestern Mutual Future Ventures, we look for partners who are developing tools and platforms to help us deliver the experience clients need, want and deserve; who are shaping the future of health and wellness; and who are bringing new technologies and enhanced analytics to market. Cream City Venture Capital: We're committed to being a catalyst for business growth in our home town. Cream City Venture Capital is dedicated to investing solely in startups based in southeast Wisconsin. Beyond capital, Cream City Venture Capital portfolio companies get access to our network of mentors and state-of-the-art co-working space. We look to partner with companies that are leveraging technology to address challenges across any industry. More Than Just Funding We support and drive growth with value-add platform services, connecting our portfolio companies to resources within and outside of Northwestern Mutual. By accelerating learning and connecting to experts, we can help founders quickly overcome growth challenges and increase the likelihood of their startup’s success. Leveraging Northwestern Mutual: Industry insights and expertise gained over 160+ years Business Development: Strategic connections to potential partners or customers Talent & Leadership Development: Growing and developing founders and their teams as they grow their business Marketing & Communication: Amplification of founders’ personal and company brands through consultation with Northwestern Mutual’s experts Community & Events: Access to best practices and opportunities by connecting with other founders, Northwestern Mutual executives and influencers Investing in and Supporting Startups Founded by Women and Black Entrepreneurs Female-founded startups receive less than three percent of the approximately $80 billion in venture capital annually, and Black founders receive less than one percent. As part of our ongoing commitment to women and diversity, we’ve dedicated a total of $40 million to investing in startup companies founded by women and Black entrepreneurs. This funding allocation will advance the company’s investment strategy of engaging startups whose technologies have the potential to transform how clients experience financial security, as well as increase focus on technological disruption. The investment criteria align with NM Future Ventures' key strategic areas of focus.

Like Benjamin Franklin knotting a key to a kite in a lightning storm, today’s AI researchers are unlocking technology that is reshaping our world. From quantum neural networks and transformers for NLP, to AI for drug discovery, the path to future innovations and commercialization is charted by a small subset of the global technology talent pool, the elite AI researchers. Coalescing around the pioneers of AI, including Toronto’s “godfather of deep learning” Geoffrey Hinton, this AI talent pool has laid the foundations for innovation and rapid commercialization. Radical is both a product of the Canada AI ecosystem and one of its architects. Radical founders Jordan Jacobs and Tomi Poutanen helped co-author the world’s first national AI strategy and conceived of and co-founded the Vector Institute for Artificial Intelligence, alongside Geoffrey Hinton, Ed Clark and others in 2017. Vector began with 8 faculty and is now home to over 1700 of the world’s top AI researchers. Before Radical, Jordan and Tomi founded Milq in 2011 and then spun-out Layer 6 AI in 2016, an AI prediction platform company later acquired by TD Bank, where they became co-Chief AI Officers. As founders, ecosystem builders and investors, the Radical team has played an active role in nurturing the next generation of AI innovation and commercialization. Just as Thomas Edison would build upon Franklin’s discoveries, now is the moment to capitalize on the opportunity afforded by innovations in AI. Every facet of our economy and lives stand to benefit from breakthroughs in AI. Like today’s electrical grid, AI will soon power nearly every human interaction with technology. Lightning to light bulb. That is the transformative moment we are investing in.

We are at the forefront of revolutionary technologies disrupting industries and transforming human life at an accelerating pace towards singularity. Like the high-performance racing teams of Formula 1, we compete to lead premier investments in the world's most exceptional unicorns - hence «Frontline One»

We are dedicated team of experienced investors who help to enable groundbreaking work by investing in and fostering companies and technologies that advance the future of health. Entrepreneur-friendly strategic investor that speeds access to new healthcare products and services to improve patient care Established by UNC REX Healthcare in 2012 as part of its commitment to innovation Partners with emerging companies throughout North Carolina and the U.S. Leverages the talent and subject matter experts across the UNC REX and UNC Health Care network

We are investors in the B2B and Enterprise Space. Built in India for the World: Cloud-based, enterprise-first digital companies being built in India and focused on global markets. ESG-Positive: Fintech, Healthtech, Mobility, Cleantech and Agritech companies for aspirational India​ and other markets. Emerging Technologies: Backing companies and entrepreneurs in breakout areas (deep tech, space tech, web3, AR/VR etc.) for the next decade. We pride ourselves in being the investor our portfolio founders value most on their cap table, with equalamounts of constructive challenge and unconditional support. With our Morphosis 3/6 Acceleration Model, we source and supercharge growth for the right investment opportunities. We are investing in proprietary technology that our portfolio companies can leverage to accelerate growth while also allowing our funds to source and screen investment opportunities more meaningfully.